Paragon 28 (DE:7GQ)
FRANKFURT:7GQ

Paragon 28 Stock Price & Analysis

0 Followers

7GQ Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€14.00 - €20.20
Previous Close€18.8
Volume0.00
Average Volume (3M)160.00
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$56.33M
Total Debt (Recent Filing)$43.23M
Price to Earnings (P/E)N/A
Beta1.02
Next EarningsMar 07, 2023
EPS Estimate-€0.09
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)N/A
Shares Outstanding77,126,895
R-SquaredN/A
Standard DeviationN/A
10 Day Avg. Volume0
30 Day Avg. Volume160
Price to Book (P/B)12.50
Price to Sales (P/S)8.35
Price to Cash Flow (P/CF)311.30
P/FCF Ratio-15.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside46.43% Upside
Rating ConsensusStrong Buy
AlphaN/A
Number of Analyst Covering3


Financials


7GQ FAQ

What was Paragon 28’s price range in the past 12 months?
Paragon 28 lowest stock price was €14.00 and its highest was €20.20 in the past 12 months.
    What is Paragon 28’s market cap?
    Currently, no data Available
    When is Paragon 28’s upcoming earnings report date?
    Paragon 28’s upcoming earnings report date is Mar 07, 2023 which is in 101 days.
      How were Paragon 28’s earnings last quarter?
      Paragon 28 released its earnings results on Nov 10, 2022. The company reported -€0.125 earnings per share for the quarter, missing the consensus estimate of -€0.111 by -€0.013.
        Is Paragon 28 overvalued?
        According to Wall Street analysts Paragon 28’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Paragon 28 pay dividends?
          Paragon 28 does not currently pay dividends.
          What is Paragon 28’s EPS estimate?
          Paragon 28’s EPS estimate is -€0.09.
            How many shares outstanding does Paragon 28 have?
            Currently, no data Available
            What happened to Paragon 28’s price movement after its last earnings report?
            Paragon 28 reported an EPS of -€0.125 in its last earnings report, missing expectations of -€0.111. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Paragon 28?
              Currently, no hedge funds are holding shares in DE:7GQ

              ---

              Paragon 28 Stock Smart Score

              5
              Neutral
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              -4.63%
              12-Months-Change

              Fundamentals

              Return on Equity
              -29.14%
              Trailing 12-Months
              Asset Growth
              111.41%
              Trailing 12-Months
              The Paragon 28 Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Paragon 28

              Paragon 28 Inc is a medical devices company that develops, distributes, and sells medical devices in the foot and ankle segment of the orthopedic implant marketplace. Its products include plates and plating systems, screws, staples, and nails aimed to address all major foot and ankle procedures including ankle, charcot, fracture fixation, hallux valgus, hammertoe, and flatfoot.

              ---

              Forecast EPS vs Actual EPS


              Similar Stocks
              Company
              Price & Change
              Follow
              Abbott Labs
              Intuitive Surgical
              Stryker
              Becton Dickinson
              Edwards Lifesciences

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis